Chicago Partners Investment Group LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 13.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,077 shares of the healthcare conglomerate’s stock after buying an additional 128 shares during the period. Chicago Partners Investment Group LLC’s holdings in UnitedHealth Group were worth $346,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. JJJ Advisors Inc. boosted its position in shares of UnitedHealth Group by 1,820.0% in the third quarter. JJJ Advisors Inc. now owns 96 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 91 shares during the period. Knuff & Co LLC boosted its position in shares of UnitedHealth Group by 666.7% in the third quarter. Knuff & Co LLC now owns 115 shares of the healthcare conglomerate’s stock worth $36,000 after buying an additional 100 shares during the period. Old North State Trust LLC purchased a new stake in shares of UnitedHealth Group in the third quarter worth about $39,000. Exchange Traded Concepts LLC lifted its stake in shares of UnitedHealth Group by 140.0% in the second quarter. Exchange Traded Concepts LLC now owns 132 shares of the healthcare conglomerate’s stock worth $39,000 after acquiring an additional 77 shares in the last quarter. Finally, Clean Yield Group lifted its stake in shares of UnitedHealth Group by 38.5% in the third quarter. Clean Yield Group now owns 144 shares of the healthcare conglomerate’s stock worth $45,000 after acquiring an additional 40 shares in the last quarter. 86.39% of the stock is owned by institutional investors.
In related news, EVP Marianne D. Short sold 10,336 shares of the stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $312.34, for a total value of $3,228,346.24. Also, Director Stephen J. Hemsley sold 98,579 shares of the stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $329.47, for a total value of $32,478,823.13. The disclosure for this sale can be found here. 0.80% of the stock is currently owned by corporate insiders.
Several research analysts recently commented on the company. Jefferies Financial Group boosted their price target on UnitedHealth Group from $310.00 to $335.00 and gave the stock a “hold” rating in a research note on Thursday, October 15th. Mizuho boosted their price target on UnitedHealth Group from $361.00 to $380.00 and gave the stock a “buy” rating in a research note on Monday, November 9th. Argus cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, October 19th. Royal Bank of Canada boosted their price target on UnitedHealth Group from $384.00 to $389.00 and gave the stock an “outperform” rating in a research note on Thursday, October 15th. Finally, UBS Group boosted their price target on UnitedHealth Group from $319.00 to $330.00 and gave the stock a “neutral” rating in a research note on Friday, October 16th. Six investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $352.64.
Shares of UnitedHealth Group stock opened at $355.67 on Monday. The company has a current ratio of 0.82, a quick ratio of 0.84 and a debt-to-equity ratio of 0.59. The business’s 50 day simple moving average is $323.61 and its 200-day simple moving average is $306.82. The stock has a market capitalization of $337.47 billion, a price-to-earnings ratio of 20.43, a PEG ratio of 1.53 and a beta of 0.68. UnitedHealth Group Incorporated has a twelve month low of $187.72 and a twelve month high of $367.95.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share for the quarter, topping analysts’ consensus estimates of $2.98 by $0.53. The business had revenue of $65.12 billion for the quarter, compared to analysts’ expectations of $63.97 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the firm earned $3.88 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 16.78 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date of this dividend is Friday, December 4th. UnitedHealth Group’s payout ratio is 33.09%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Read More: Which market index is the best?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.